Keith Wille, | |
1717 6th Ave S, Birmingham, AL 35233-1801 | |
(800) 822-8816 | |
Not Available |
Full Name | Keith Wille |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 30 Years |
Location | 1717 6th Ave S, Birmingham, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285658336 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | 19147 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Alabama Hospital | Birmingham, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.
At the 1st annual Society for Laboratory Automation and Screening Conference in San Diego (Booth #711), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing several new drug discovery technologies and applications - including innovative products based on the Company's ALPHA technology and LANCE Ultra technologies for epigenetics research.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Robert Schroth, University of Manitoba, Children's Hospital Research Institute of Manitoba, Winnipeg, Canada, will present a study titled "Microbiome Associated With Severe Caries in Canadian First Nations Children." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
"Exposure to mercury can cause severe health damage, particularly to pregnant women and young children," said Lockyer. "If implemented, these rules will protect the profits of polluters at the expense of the environment, people and public health."
› Verified 4 days ago
Entity Name | University Of Alabama Health Services Foundation, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.
At the 1st annual Society for Laboratory Automation and Screening Conference in San Diego (Booth #711), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing several new drug discovery technologies and applications - including innovative products based on the Company's ALPHA technology and LANCE Ultra technologies for epigenetics research.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Robert Schroth, University of Manitoba, Children's Hospital Research Institute of Manitoba, Winnipeg, Canada, will present a study titled "Microbiome Associated With Severe Caries in Canadian First Nations Children." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
"Exposure to mercury can cause severe health damage, particularly to pregnant women and young children," said Lockyer. "If implemented, these rules will protect the profits of polluters at the expense of the environment, people and public health."
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Keith Wille, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: () - | Keith Wille, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (800) 822-8816 |
News Archive
Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.
At the 1st annual Society for Laboratory Automation and Screening Conference in San Diego (Booth #711), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing several new drug discovery technologies and applications - including innovative products based on the Company's ALPHA technology and LANCE Ultra technologies for epigenetics research.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Robert Schroth, University of Manitoba, Children's Hospital Research Institute of Manitoba, Winnipeg, Canada, will present a study titled "Microbiome Associated With Severe Caries in Canadian First Nations Children." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
"Exposure to mercury can cause severe health damage, particularly to pregnant women and young children," said Lockyer. "If implemented, these rules will protect the profits of polluters at the expense of the environment, people and public health."
› Verified 4 days ago
Juan Mario Bernal, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243 Phone: 205-971-7500 | |
Dr. William Randolph Maddox, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3000 Fax: 205-297-9411 | |
Jodie Ann Dionne, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233 Phone: 205-975-6530 | |
Dr. Karl Tullio Schroeder, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211 Phone: 205-780-1920 Fax: 205-780-2345 | |
Dr. Deepti Bahl, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Amitkumar Mehta, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294 Phone: 205-996-8400 Fax: 205-934-1608 | |
Shana Monika Machado, D.O. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |